Skip to content
AwardedNetherlandsGoods€5,000,000

Afmelding DKT-vaccins - RIVM & GSK

Published
Published 20 March 2025

Overview

Levering van vaccines Purchaser desires to purchase x doses in the first contract year, x (±15%) doses in the second contract year and x (±15%) doses in the third contract year. The shelf life of Boostrix ®

Key details

Country
Netherlands
Status
Awarded
Category
Goods
Estimated value
€5,000,000
Procedure
Direct
Published
20 March 2025
Classification (CPV)
Pharmaceutical productsVaccines

Award outcome

Awarded value
€4,775,550
Award date
7 March 2025
Contract period
— → 20 February 2028
Winner
  • GlaxoSmithKline B.V.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    20 March 2025

Contracting authority

  • Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

    Procuring entity

    Bilthoven, Netherlands

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Afmelding DKT-vaccins - RIVM & GSK — won by GlaxoSmithKline B.V. — Skim